Patent details

EP1191926 Title: NEW OMEPRAZOLE AND (S)-OMEPRAZOLE FORMULATION

Basic Information

Publication number:
EP1191926
PCT Application Number:
PCT/SE/2000/001310
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP009466145
PCT Publication Number:
WO/2000/078293
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
NEW OMEPRAZOLE AND (S)-OMEPRAZOLE FORMULATION
French Title of Invention:
NOUVELLE FORMULATION DE OMEPRAZOLE ET (S)-OMEPRAZOLE
German Title of Invention:
NEUE OMEPRAZOLE UND (S)-OMEPRAZOLE ZUSAMMENSETZUNG
SPC Number:

Dates

Filing date:
20/06/2000
Grant date:
30/03/2005
EP Publication Date:
30/03/2005
PCT Publication Date:
28/12/2000
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
03/04/2002
EP B1 Publication Date:
30/03/2005
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
20/06/2009
Expiration date:
20/06/2020
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
20/06/2000
 
 

Name:
AstraZeneca AB
Address:
-, 151 85 Södertälje, Sweden (SE)

Agent

Name:
FRIEDERICH PIERRE
From:
25/04/2005
Address:
ROUTE D'ARLON 261, 8002, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
LUNDBERG Per, Johan
Address:
Sweden (SE)

2

Name:
SJÖBLOM Brita
Address:
Sweden (SE)

Priority

Priority Number:
9902386
Priority Date:
22/06/1999
Priority Country:
Sweden (SE)

Classification

Main IPC Class:
A61K 9/36;
Filing date Document type Number of pages